Short-term exposure to an experimental drug reverses age-related memory decline and cognitive deficits in mice. The drug, ISRIB, has previously shown beneficial effects in treating memory loss associated with TBI and other neurological disorders.
Short-term exposure to an experimental drug reverses age-related memory decline and cognitive deficits in mice. The drug, ISRIB, has previously shown beneficial effects in treating memory loss associated with TBI and other neurological disorders.